View Older Stories View More Recent Stories
-
AlloVir (ALVR) Announces 95% Workforce Reduction
-
Intellia Therapeutics (NTLA) Highlights its Three-Year Strategic Priorities, Anticipated 2024 Milestones
-
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
-
Weekly US jobless claims fall to two-month low; labor market steadily cooling
-
TransCode Therapeutics (RNAZ) Publishes Open Letter to Shareholders, Proposed Reverse Split
-
TransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives
-
US job cuts fall back in December but nearly double for all of 2023
-
Wolfe Research Upgrades ADP (ADP) to Peerperform, 'we believe the bar has been set at a more reasonable spot'
-
Marketmind: Fed minutes calm the horses
-
Explainer-Charting the Fed's economic data flow
-
Benchmark names Spotify (SPOT) as 'Top Pick' in 2024
-
Xerox (XRX) shares fall after company announces 15% workforce reduction
-
Xerox (XRX) Announces New Operating Model and Organizational Structure
-
Xerox Reinvention and Operating Model Evolution
-
Investors pin hopes on Canada's mid-sized EQ Bank after blockbuster 2023
-
McDonald's Malaysia sues Israel boycott movement for $1 million in damages
-
UK factory revival prospects suffer setback in December - PMI
-
McDonald's Malaysia sues Israel boycott movement for $1 million in damages
-
Early-Stage Biotech Investments Were Down 40% in 2023: Novotech Whitepaper
-
Getty Images (GETY) Announced as an Official Photo Distribution and Licensing Provider of the College Football Playoff
-
Math Ain't Mathing? Celebrate Kwanzaa with Automation Workz Vision Board App
-
Why Novocure stock is up today?
-
The most important questions for 2024 - Goldman Sachs
-
AI Revolution: Embrace Your Next Partner-In-Crime, Not Job Terminator
-
Wall Street analysts trim Chevron views as setbacks mount
-
Nike's powerhouse labels lose footing against upstart brands - analysts
-
Poxel Provides Corporate Update
-
Citigroup to shut global distressed-debt business - CNBC
-
Guardian Finds Caregivers Face Unprecedented Challenges, Impacting Overall Well-being
-
Starco Brands Announces Record-Breaking Performance of Skylar, Reinforcing Its Position as a Leader in the Clean Fragrance Sector
-
Steelcase Reports Third Quarter Fiscal 2024 Results
-
Goldman Sachs plans 10% bonus hike for dealmakers despite 2023 job cuts - Financial News
-
Enphase Energy to cut 10% of staff
-
FMC Corp. (FMC) Initiates Global Restructuring Plan
-
Forvia aims to halve its R&D costs by 2028 thanks to AI-CEO
-
AI can create more jobs than it potentially eliminates: Tech Mahindra's outgoing CEO
-
Delivery Hero to close tech hubs in Turkey and Taiwan, cut jobs
-
Exclusive-Fed's Bostic sees two rate cuts, soft landing next year
-
Nio (NIO) to bring Firefly brand to Europe in 2025
-
GM’s Cruise to cut workforce by 24%
-
Foreign multinationals in Ireland shed jobs for first time since 2009
-
French business activity contracts more than expected in December -flash PMI
-
Asian IPO market seen brighter in 2024 but elections cast shadows
-
GM to lay off 1,300 workers at two Michigan plants
-
GM's struggling Cruise business to cut one-quarter of its workforce
-
New Data from Inspira AI Predicts: Nine out of 10 Office Jobs Gone Forever as a Result of AI
-
Reneo Pharmaceuticals (RPHM) Reports Results from Pivotal STRIDE Study of Mavodelpar
-
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
-
Clearside Biomedical (CLSD) Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
-
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
